Return to content in this issue


From MASK-air® and SILAM to CATALYSE (Climate Action to Advance HeaLthY Societies in Europe)

Sousa-Pinto B1,2*, Palamarchuk Y3*, Leemann L4, Jankin S5, Basagaña X6,23-25, Ballester J6, Bedbrook A7, Czarlewski W7, Almeida R1,2, Haahtela T8, Haveri H9, Prass M27,28, Henriques T1,2, Vieira RJ1,2, Klimek L10,11, Ollert M12-14, Shamji MH15,16, Jutel M17,18, Del Giacco S19, Torres MJ20, Zuberbier T21,22, Fonseca JA1,2**, Sofiev M3**, Anto JM6,24,25**, Bousquet J7,21,22,26**

1MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal
2CINTESIS@RISE - Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal
3Finnish Meteorological Institute (FMI), Helsinki, Finland
4Department of Political Science, University of Zürich, Zurich, Switerland
5Data Science Lab, Hertie School, Berlin, Germany
6ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain
7MASK-air SAS, Montpellier, France
8Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
9Health and Hospital Care Services, Wellbeing services county of Päijät-Häme, Lahti, Finland
10Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Germany
11Center for Rhinology and Allergology, Wiesbaden, Germany
12Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg
13Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark
14Department of Dermatology and Allergy Center, Odense University Hospital, Odense, Denmark
15National Heart and Lung Institute, Imperial College, London, UK
16NIHR Imperial Biomedical Research Centre, London, UK
17Department of Clinical Immunology, Wrocław Medical University, Wroclaw, Poland
18ALL-MED Medical Research Institute, Wroclaw, Poland
19Department of Medical Sciences and Public Health and Unit of Allergy and Clinical Immunology, University Hospital "Duilio Casula", University of Cagliari, Cagliari, Italy
20Allergy Unit, Regional University Hospital of Malaga, Malaga University, ARADyAL, Malaga, Spain
21Institute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
22Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany
23IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
24Universitat Pompeu Fabra (UPF), Barcelona, Spain
25CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
26University Hospital Montpellier, Montpellier, France
27Ecosystems and Environment Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Lahti, Finland
28Coordination Unit, Lahti University Campus, Lahti, Finland
*The first two authors contributed equally to the paper
**The last four authors contributed equally to the paper

J Investig Allergol Clin Immunol 2024; Vol. 34
doi: 10.18176/jiaci.0923

Plant species vary under different climate conditions and the distribution of pollen in the air and their trends can be used to assess the impact of climate change on public health. In 2015, MASK-air® (Mobile Airways Sentinel networK for rhinitis and asthma) was launched as a project of the European Innovation Partnership on Active and Healthy Ageing (EIP-on-AHA, DG Santé and DG CONNECT). This project aimed to develop a warning system to inform patients about the pollen season onset. SILAM (System for Integrated modeLling of Atmospheric composition), a global-to-meso-scale dispersion model was developed by the Finnish Meteorological Institute (FMI). It provides quantitative information on atmospheric pollution of anthropogenic and natural origins, particularly on allergenic pollens. POLLAR (Impact of Air Pollution on Asthma and Rhinitis, EIT Health) has combined MASK-air clinical data with SILAM forecasts. A new Horizon Europe grant, CATALYSE (Climate Action to Advance HeaLthY Societies in Europe; grant agreement number 101057131), which started in September 2022, aims at better understanding climate change and finding ways to counteract it. One objectives of this project is to develop early warning systems and predictive models to improve the effectiveness of adaptation strategies to climate change. One of warning system is focused on allergic rhinitis (CATALYSE Task 3.2). with a collaboration between the FMI (Finland), Porto University (Portugal), MASK-air SAS (France), ISGlobal (Spain), Hertie School (Germany) and the University of Zurich (Switzerland). It is to be implemented with the support of EAACI. This paper reports the planning of CATALYSE Task 3.2.

Key words: Catalyse, MASK-air, SILAM, Pollen, Climate change